Positive surgical margins are an independent risk factor for biochemical recurrence after radical prostatectomy. However, the identification of residual cancer by eye is highly limited, and frozen sections are not always available or possible for all margins. Prostate-specific membrane antigen-targeted fluorescence guidance might close this gap and enhance the surgeon’s eye.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moretti, T. B. C., Magna, L. A. & Reis, L. O. Open, laparoscopic, and robot-assisted radical prostatectomy oncological results: a reverse systematic review. J. Endourol. https://doi.org/10.1089/end.2022.0819 (2023).
Hollemans, E. et al. Prostate carcinoma grade and length but not cribriform architecture at positive surgical margins are predictive for biochemical recurrence after radical prostatectomy. Am. J. Surg. Pathol. 44, 191–197 (2020).
Schlomm, T. et al. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur. Urol. 62, 333–340 (2012).
Olde Heuvel, J. et al. State-of-the-art intraoperative imaging technologies for prostate margin assessment: a systematic review. Eur. Urol. Focus 7, 733–741 (2021).
Rocco, B. et al. Digital frozen sections with fluorescence confocal microscopy during robot-assisted radical prostatectomy: surgical technique. Eur. Urol. 80, 724–729 (2021).
Roberts, M. J. et al. Using PSMA imaging for prognostication in localized and advanced prostate cancer. Nat. Rev. Urol. 20, 23–47 (2023).
Darr, C. et al. Intraoperative molecular positron emission tomography imaging for intraoperative assessment of radical prostatectomy specimens. Eur. Urol. Open Sci. 54, 28–32 (2023).
Knipper, S. et al. Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via prostate-specific membrane antigen-radioguided surgery. Eur. Urol. https://doi.org/10.1016/j.eururo.2022.05.031 (2023).
Nguyen, H. G. et al. First-in-human evaluation of a prostate-specific membrane antigen–targeted near-infrared fluorescent small molecule for fluorescence-based identification of prostate cancer in patients with high-risk prostate cancer undergoing robotic-assisted prostatectomy. Eur. Urol. Oncol. https://doi.org/10.1016/j.euo.2023.07.004 (2023).
Stibbe, J. A. et al. First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial. Lancet Oncol. 24, 457–467 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Falkenbach, F., Maurer, T. PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy. Nat Rev Urol 20, 704–705 (2023). https://doi.org/10.1038/s41585-023-00817-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-023-00817-z
This article is cited by
-
Update Prostatakarzinom
CME (2024)
